|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Staphylococcus aureus continues to be a dangerous pathogen for both community-acquired as well as hospital-associated infections. Strains of S. aureus resistant to methicillin were reported soon after its introduction in October 1960.The antimicrobial chemotherapy for this species has always been empirical, because of its resistance to many therapeutic agents. This study was carried out in and around Trivandrum, Kerala to isolate MRSA from a total of 3934 clinical samples comprising of urine, pus, throat swab/sputum, nasal swab and blood. The percentage of MRSA in this study was 35.41, which is considered to be very high compared to the prevalence of MRSA in most of other published studies. In this study all the strains of MRSA were susceptible to linezolid and vancomycin and resistant to all other antibiotics trimethoprim, gentamycin, amikacin, ciprofloxacin, erythromycin and clindamycin. An antibiotic policy and the monitoring of susceptibility patterns of MRSA may also help in decreasing the prevalence of MRSA and antibiotic resistance.